(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2018, a xience alpine 3.25x18mm stent was successfully implanted in the ramus coronary artery lesion.On (b)(6) 2018, the patient was hospitalized for stable ventricular tachycardia.As treatment, an implantable cardioverter-defibrillator (icd) was placed.The event resolved without sequela.Per physician, the event was possibly related to the device.There was no device malfunction.No additional information was provided regarding this event.
|